SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is experiencing heightened volatility as investors weigh a strong beat on delivery estimates against concerns over margin compression and a potential 'sell the news' reaction. The community remains deeply divided, with bulls pointing to the record delivery figures and energy storage growth as catalysts for a rally, while bears highlight the high P/E ratio and fears that the market has already priced in the positive news.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is seeing active community debate as investors react to strong delivery guidance and reports of successful production ramps for the R2 model. Traders are closely watching key technical resistance levels while debating whether the current momentum represents a long-term fundamental breakout or a short-term volatility play.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors ramp up pressure on short sellers, fueled by anticipation of upcoming catalysts regarding global expansion and label expansion for their immunotherapy platform. The community is actively discussing the potential for a short squeeze, supported by recent price resilience and widespread optimism that the companys AI-driven manufacturing and NK cell technology are on the verge of significant international adoption.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is seeing significant bullish momentum driven by its successful selection to supply small modular reactors (SMRs) for Sweden, alongside ongoing strength in its defense contracts and aviation engine orders. Community sentiment is overwhelmingly positive, with investors closely watching for mid-year earnings and further major project announcements at upcoming airshows.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as investors debate whether the current price represents a deep value buying opportunity or a structural decline, fueled by intense community discussion over its high short interest and potential for a massive short squeeze. Shareholders are actively tracking international growth, the Alani Nu brand integration, and market rotation patterns as they wait for an earnings-driven catalyst to spark a reversal.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is currently trending due to active discussions around its growth trajectory, recent international expansion, and comparisons to established brokerage competitors like Robinhood. While some investors are optimistic about potential breakouts driven by platform innovation and institutional accumulation, others remain skeptical, pointing to persistent price volatility and recent performance struggles.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is facing significant selling pressure as investors react to reports of potential hyperscaler competition in the AI compute space, while community sentiment remains heavily polarized due to concerns over executive compensation and a lack of major customer deal announcements. Despite these headwinds, bulls continue to highlight the company's long-term infrastructure assets and power pipeline as a strategic moat in an increasingly compute-constrained market.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as analysts highlight the platform's multi-layered expansion strategy, including global market growth, the launch of Trump-backed investment accounts, and new on-chain financial products. While community sentiment is heavily polarized between bullish supporters betting on long-term platform scale and skeptics wary of high valuations and intense market volatility, the stock remains a central focus for retail traders monitoring institutional upgrades and upcoming corporate events.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is rallying as reports of a potential cloud offering to monetize excess AI compute spark community discussion about the company's ROI on massive capital expenditure. While some investors see this as a strategic move to turn capacity into a revenue stream, others remain skeptical, debating whether this signals a genuine pivot to a neocloud model or an act of desperation following AI overbuild concerns.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending following a surprise announcement of a $350 million convertible senior notes offering, an unexpected move that has sparked investor frustration given the company's existing $2 billion cash balance. While the community is actively debating whether this signals a strategic acquisition, an attempt to bolster the pipeline, or poor capital discipline, many shareholders are expressing deep dissatisfaction with management, citing the stock's long-term underperformance and the lack of clarity regarding the dilution event.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Reminder - Cardinal Health (CAH) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 7/1/26, Cardinal Health, Inc. (Symbol: CAH) will trade ex-dividend, for its quarterly dividend of $0.5158, payable on 7/15/26. As a percentage of CAH's recent stock price of $236.48, this dividend works out to a...

Why the Market Dipped But Cardinal Health (CAH) Gained Today

Cardinal Health (CAH) closed at $237.92 in the latest trading session, marking a +1.35% move from the prior day.

Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?

Here is how Bayer Aktiengesellschaft (BAYRY) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note

In the latest trading session, Cardinal Health (CAH) closed at $233.01, marking a +1.79% move from the previous day.

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?

Cardinal Health has gained nearly 8% in 2026 as specialty pharma growth, rising EPS, and expanding healthcare services fuel investor optimism.

Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors

In the closing of the recent trading day, Cardinal Health (CAH) stood at $221.77, denoting a -1.99% move from the preceding trading day.

COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?

COR shares are down 18% YTD, but rising EPS guidance, specialty pharma growth and strategic expansion could make this pullback worth watching.

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Cardinal Health, Inc.

Cardinal Health Opens Distribution Center In Texas, Plans One In California 

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$2.41	--	--	N/A
Q3 '26	$2.79	$3.17	13.43%	BEAT
Q2 '26	$2.34	$2.63	12.35%	BEAT
Q1 '26	$2.18	$2.55	16.87%	BEAT
Q4 '25	$2.04	$2.08	2.09%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

CAHCardinal Health, Inc.

Upcoming Earnings: Q4 '26

Historical Earnings

Latest CAH News